MD Anderson Research Highlights for Aug. 24
August 25, 2022
August 25, 2022
HOUSTON, Texas, Aug. 25 (TNSjou) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
Featuring rising response rates in Phase I trials, targeted therapy and cell therapy advances for B-cell lymphomas, and promising combination therapies in several cancers
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clin . . .
* * *
Featuring rising response rates in Phase I trials, targeted therapy and cell therapy advances for B-cell lymphomas, and promising combination therapies in several cancers
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clin . . .